BDO Wealth Advisors’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$6.98K Hold
950
﹤0.01% 742
2023
Q1
$9.84K Buy
+950
New +$11.5K ﹤0.01% 707
2022
Q3
Sell
-19
Closed -$1K 1057
2022
Q2
$1K Hold
19
﹤0.01% 961
2022
Q1
$1K Hold
19
﹤0.01% 982
2021
Q4
$1K Hold
19
﹤0.01% 1007
2021
Q3
$1K Hold
19
﹤0.01% 994
2021
Q2
$1K Hold
19
﹤0.01% 1042
2021
Q1
$2K Hold
19
﹤0.01% 979
2020
Q4
$2K Hold
19
﹤0.01% 760
2020
Q3
$2K Buy
+19
New +$2.05K ﹤0.01% 679

Other funds holding EBS

BDO Wealth Advisors's EBS Position: Q2 2023 in Review

BDO Wealth Advisors held its Emergent Biosolutions (EBS) position steady in Q2 2023 at 950 shares worth $6.98K. The position accounts for ﹤0.01% of the portfolio, ranked #742.

BDO Wealth Advisors first reported a position in EBS in Q3 2020 and has held it in 10 quarters since. The position peaked at $9.84K in Q1 2023. 183 funds tracked by Wall St. Rank hold EBS as of Q2 2023.

  • BDO Wealth Advisors held 950 shares of Emergent Biosolutions worth $6.98K as of Q2 2023.
  • BDO Wealth Advisors left its Emergent Biosolutions share count unchanged in Q2 2023.
  • Emergent Biosolutions made up ﹤0.01% of BDO Wealth Advisors's portfolio in Q2 2023, its #742 holding.
  • BDO Wealth Advisors first reported a position in Emergent Biosolutions in Q3 2020 and has held it in 10 quarters since.
  • BDO Wealth Advisors's Emergent Biosolutions position peaked at $9.84K in Q1 2023.
  • 183 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2023.

Based on BDO Wealth Advisors's 13F filing for Q2 2023, filed 1 Aug 2023.